IRT
Trials conducted
in 80 countries
Average UAT defects
targeting ≤5 for moderate
& cosmetic defects
0n time delivery
for customer acceptance
Clinical trial complexity, meet our rich IRT functionality. Now you can address unique needs—and hit tight timelines.
A robust foundation of essential core IRT features. Each focused on meeting the requirements of common protocols in complex decentralized, patient-centric trials for therapeutic areas such as oncology, central nervous system, and rare disease. The tools to create new, client-custom functionality. All developed as easy-to-assemble building blocks. So our services teams can support the unique needs of each trial.
In addition to an advanced architecture that allows for fast and comprehensive functionality, our IRT system also includes extensive configurability options. It’s how we enable study teams to adjust system functionality to meet the ever-changing demands of their trial. Because no two of our clients’ trials are exactly alike, but all share a world of complexity. And all need to move with speed.
Trial Logistics
-
Roles, permissions, and blinding management
-
Study and site administration
-
Cohort/stage/phase management
-
Dynamic cohort and dose management
-
Additional and dynamic visit schedule
Patient Logistics
-
Subject management
-
Adaptive replacement and randomization
-
Cross-over and re-treatment
-
Open-label extension
-
Dose calculation
-
Subject roll-over
-
Dose modification and interruption
Drug Logistics
-
Drug dispensing management
-
Drug supply management
-
Drug accountability, reconciliation, and returns/destruction management
-
Temperature excursion management
-
Controlled substance management
-
Variable drug sourcing
-
Central pharmacy
-
Direct-to-patient shipping
-
Robust supply strategy management
Built to embrace the unknown. Because your IRT should be as ready for change as you are.
The scientific process isn’t static. And neither is your trial. To collect the richest data, protocols must be amended as new information is obtained. That’s why we designed the Suvoda IRT to adapt mid-study with ease.
Commonly-needed additions, modifications, and corrections to study, site, drug management, and administrative functions can be made by permissioned users within our system after go-live. This puts control in your hands and reduces the time and costs associated with change-orders. And if more significant updates are required, our modular architecture makes it a simple and speedy process for your dedicated Suvoda project team to add in new IRT features.
A user-friendly IRT experience eases decisive action for users of all experience levels.
We find that people are more likely to work at their best when they’re using the tools they like best.
That’s why, no matter the level of experience with clinical trial technology—from dedicated pros to more occasional site-users, and even home caregivers—you’ll find interactions with the Suvoda IRT are universally simple. It’s the result of a minimalist look and feel, intuitive navigation, and patient-centric workflow. And it’s all intended to drive focus on the immediate task at hand.
See the way to long-term trial performance, in real time, with pre-set and ad-hoc reports and advanced analytics.
Suvoda IRT pre-set and ad-hoc reports give you up-to-the-minute visualizations of data points, KPIs, and trends on the subjects, sites, drugs, and depots within a given study. It’s how you’ll always know where you stand—and what needs your attention.
Why such robust reporting? To give you the intelligence you need to make better decisions in executing on today’s trials—and planning for tomorrow’s.
FEATURED IRT MODULES
Take command of the cold supply chain
Gain control in a world of decentralized trials
Gain control in a world of decentralized trials
Broad perspective. Keen insight. Calm guidance.
Broad perspective. Keen insight. Calm guidance.
Seamless technology in complex ecosystems
Seamless technology in complex ecosystems
INSIGHTS & NEWS
-
BLOG
Electronic Clinical Outcome Assessments (eCOA) in Clinical Trials
Sep 12, 2024 -
BLOG
4 Factors That Shape a Technical Direction That Lasts
Sep 5, 2024 -
NEWS
The cornerstone of clinical trial success: selecting seasoned CDMOs and IRT vendors
Sep 3, 2024 -
BLOG
Improving Informed Consent: A Closer Look at the Draft FDA Guidance for Patient Understanding
Aug 30, 2024 -
BLOG
How thoughtful adaptation in clinical trials can bring new medicines to market faster
Aug 15, 2024 -
BLOG
The benefits of real-time data for CROs
Jul 24, 2024 -
BLOG
Why drug pooling remains important to clinical trials
Jul 23, 2024 -
BLOG
Decoding eCOA trends: adoption predicted to rise
Jul 11, 2024 -
NEWS
Suvoda Expands its Clinical Trial Offering with the Introduction of ePatient
Jun 26, 2024 -
BLOG
How CROs can meet timelines by selecting fit-for-purpose technology to run their trials
Jun 26, 2024